Search Results - "Wolko, Denise"

Efficacy and Safety Results of Prolong-9FP Clinical Program of Recombinant Fusion Protein Linking Coagulation Factor IX with Albumin (rIX-FP) in Previously Treated Patients with Hemophilia B by Santagostino, Elena, Voigt, Christine, Wolko, Denise, Cole, Grace, Li, Yanyan, Jacobs, Iris C.

“…▪ A fusion protein genetically linking recombinant human coagulation FIX with recombinant human albumin (rIX-FP) has been developed with an improved PK…”
Get full text

Long-Term Use of Coagulation Factor IX (Recombinant) Albumin Fusion Protein (rIX-FP) in Previously Treated Patients with Hemophilia B in the Prolong-9FP Program by Lubetsky, Aaron, Martinowitz, Uri, Lissitchkov, Toshko, Voigt, Christine, Wolko, Denise, Jacobs, Iris C., Santagostino, Elena

“…A fusion protein genetically linking recombinant human coagulation FIX with recombinant human albumin (rIX-FP) has been developed with an improved PK profile,…”
Get full text

Efficacy and Safety of Recombinant Fusion Protein Linking Coagulation Factor IX with Albumin (rIX-FP) in Previously Treated Patients with Hemophilia B Undergoing Major Orthopedic Surgeries by Negrier, Claude, Lepatan, Lynda Mae, Karim, Faralzah, Lienhart, Anne, Wolko, Denise, Voigt, Christine, Jacobs, Iris C., Santagostino, Elena

“…A fusion protein genetically linking recombinant human coagulation FIX with recombinant human albumin (rIX-FP) has been developed with an improved PK profile,…”
Get full text

The Safety of an Adenosine A1-Receptor Antagonist, Rolofylline, in Patients with Acute Heart Failure and Renal Impairment: Findings from PROTECT by Teerlink, John R., Iragui, Vicente J., Mohr, Jay P., Carson, Peter E., Hauptman, Paul J., Lovett, David H., Miller, Alan B., Piña, Ileana L., Thomson, Scott, Varosy, Paul D., Zile, Michael R., Cleland, John G. F., Givertz, Michael M., Metra, Marco, Ponikowski, Piotr, Voors, Adriaan A., Davison, Beth A., Cotter, Gad, Wolko, Denise, DeLucca, Paul, Salerno, Christina M., Mansoor, George A., Dittrich, Howard, O’Connor, Christopher M., Massie, Barry M.

“…Background: Adenosine exerts actions in multiple organ systems, and adenosine receptors are a therapeutic target in many development programmes. Objective: The…”
Get full text

The safety of an adenosine A(1)-receptor antagonist, rolofylline, in patients with acute heart failure and renal impairment: findings from PROTECT by Teerlink, John R, Iragui, Vicente J, Mohr, Jay P, Carson, Peter E, Hauptman, Paul J, Lovett, David H, Miller, Alan B, Piña, Ileana L, Thomson, Scott, Varosy, Paul D, Zile, Michael R, Cleland, John G F, Givertz, Michael M, Metra, Marco, Ponikowski, Piotr, Voors, Adriaan A, Davison, Beth A, Cotter, Gad, Wolko, Denise, Delucca, Paul, Salerno, Christina M, Mansoor, George A, Dittrich, Howard, O'Connor, Christopher M, Massie, Barry M

“…Adenosine exerts actions in multiple organ systems, and adenosine receptors are a therapeutic target in many development programmes. The aim of this analysis…”
Get more information

The Safety of an Adenosine A[subscript] 1[/subscript] -Receptor Antagonist, Rolofylline, in Patients with Acute Heart Failure and Renal Impairment by Teerlink, John R, Iragui, Vicente J, Mohr, Jay P, Carson, Peter E, Hauptman, Paul J, Lovett, David H, Miller, Alan B, Piña, Ileana L, Thomson, Scott, Varosy, Paul D, Zile, Michael R, Cleland, John GF, Givertz, Michael M, Metra, Marco, Ponikowski, Piotr, Voors, Adriaan A, Davison, Beth A, Cotter, Gad, Wolko, Denise, DeLucca, Paul, Salerno, Christina M, Mansoor, George A, Dittrich, Howard, O'Connor, Christopher M, Massie, Barry M

“…Background: Adenosine exerts actions in multiple organ systems, and adenosine receptors are a therapeutic target in many development programmes. Objective: The…”
Get full text